S&P 500 storm past 1,100

gainers, while rose 2.7% even after a new study showed its Zetia cholesterol drug was inferior to Abbott Laboratories' Niaspan at clearing clogged arteries. The Standard & Poor's 500 Index /quotes/comstock/21z!i1:in\x (SPX 1,110, +16.52, +1.51%) rose 17...